Methylenedioxymethoxyethylamphetamine
Appearance
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Innerstream (talk | contribs) at 03:51, 12 February 2025. The present address (URL) is a permanent link to this version.Revision as of 03:51, 12 February 2025 by Innerstream (talk | contribs)
Names | |
---|---|
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-(2-methoxyethyl)propan-2-amine | |
Identifiers | |
| |
3D model (JSmol)
|
|
ChemSpider |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C13H19NO3 | |
Molar mass | 237.295 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
MDMEOET (3,4-methylenedioxy-N-methoxyethylamphetamine]]) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxyethyl analogue of MDA. MDMEOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved) , the minimum dosage is listed as 180 mg. MDMEOET produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEOET.
Legality
[edit ]United Kingdom
[edit ]This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]
See also
[edit ]References
[edit ]- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
External links
[edit ]
Stub icon
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.